Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-08-11 Purchase |
2023-08-14 4:41 pm |
Mirati Therapeutics Inc. | MRTX | Hasnain Faheem Director |
10,791 | $27.8 | $299,990 | 25,841 (Indirect Direct) |
View |
2023-06-02 Sale |
2023-06-02 7:15 pm |
Mirati Therapeutics Inc. | MRTX | Stelzer Laurie Chief Financial Officer |
4,647 | $37.06 | $172,218 | 80,015 (Direct) |
View |
2023-05-24 Sale |
2023-05-24 7:38 pm |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP & Chief Scientific Officer |
619 | $45.29 | $28,035 | 124,123 (Direct) |
View |
2023-01-18 Sale |
2023-01-20 09:20 am |
Mirati Therapeutics Inc. | MRTX | Cherrington Julie M Director |
2,546 | $44.66 | $113,704 | 0 (Direct) |
View |
2023-01-17 Sale |
2023-01-19 09:45 am |
Mirati Therapeutics Inc. | MRTX | Meek David D. Chief Executive Officer |
3,179 | $42.38 | $134,715 | 61,792 (Direct) |
View |
2023-01-17 Sale |
2023-01-19 09:45 am |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP, Chief Scientific Officer |
2,245 | $42.38 | $95,142 | 97,878 (Direct) |
View |
2023-01-17 Sale |
2023-01-19 09:45 am |
Mirati Therapeutics Inc. | MRTX | Hickey Benjamin EVP, Chief Commercial Officer |
1,566 | $42.38 | $66,366 | 47,223 (Direct) |
View |
2023-01-09 Sale |
2023-01-10 5:00 pm |
Mirati Therapeutics Inc. | MRTX | Hickey Benjamin EVP, Chief Commercial Officer |
2,088 | $45.37 | $94,733 | 48,789 (Direct) |
View |
2023-01-04 Sale |
2023-01-05 5:13 pm |
Mirati Therapeutics Inc. | MRTX | BAUM CHARLES M President,Founder,Head of R&D |
3,648 | $46.6 | $169,997 | 168,777 (Direct) |
View |
2023-01-04 Sale |
2023-01-05 5:13 pm |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP, Chief Scientific Officer |
1,949 | $46.6 | $90,823 | 100,123 (Direct) |
View |
2022-12-21 Sale |
2022-12-21 9:21 pm |
Mirati Therapeutics Inc. | MRTX | BAUM CHARLES M President,Founder,Head of R&D |
9,092 | $40.42 | $367,469 | 172,425 (Direct) |
View |
2022-12-21 Sale |
2022-12-21 9:20 pm |
Mirati Therapeutics Inc. | MRTX | Hickey Benjamin EVP, Chief Commercial Officer |
3,248 | $40.41 | $131,266 | 50,877 (Direct) |
View |
2022-12-21 Sale |
2022-12-21 9:20 pm |
Mirati Therapeutics Inc. | MRTX | Meek David D. Chief Executive Officer |
4,616 | $40.41 | $186,552 | 64,971 (Direct) |
View |
2022-12-16 Sale |
2022-12-20 4:02 pm |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP, Chief Scientific Officer |
2,410 | $43 | $103,624 | 102,072 (Direct) |
View |
2022-12-02 Sale |
2022-12-05 5:00 pm |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP, Chief Scientific Officer |
1,726 | $90.19 | $155,667 | 104,482 (Direct) |
View |
2022-11-28 Sale |
2022-11-28 7:01 pm |
Mirati Therapeutics Inc. | MRTX | BAUM CHARLES M President,Founder,Head of R&D |
69,256 | $100 | $6,925,600 | 197,157 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-08-09 Option Award |
2023-08-10 4:26 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Stelzer Laurie Chief Financial Officer |
22,297 | $37 | 102,312 (Direct) |
View |
2023-08-09 Option Award |
2023-08-10 4:24 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | BAUM CHARLES M Interim CEO |
54,054 | $37 | 227,275 (Direct) |
View |
2023-08-09 Option Award |
2023-08-10 4:23 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Hickey Benjamin EVP, Chief Commercial Officer |
22,297 | $37 | 105,914 (Direct) |
View |
2023-08-09 Option Award |
2023-08-10 4:22 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Moriarty John B Chief Legal Officer |
22,297 | $37 | 71,660 (Direct) |
View |
2023-08-09 Option Award |
2023-08-10 4:21 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP & Chief Scientific Officer |
22,297 | $37 | 146,420 (Direct) |
View |
2023-08-09 Option Award |
2023-08-10 4:19 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Sandler Alan B. Chief Medical Officer |
22,297 | $37 | 62,297 (Direct) |
View |
2023-06-22 Option Award |
2023-06-23 5:18 pm |
N/A 2023-06-22 |
Mirati Therapeutics Inc. | MRTX | Gallagher Carol Giltner Director |
20,339 | $0 | 20,339 (Direct) |
View |
Ownership |
2023-06-23 5:16 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Gallagher Carol Giltner Director |
0 | $0 | 0 (Direct) |
View |
Ownership |
2023-06-23 5:15 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Moriarty John B Chief Legal Officer |
0 | $0 | 132,888 (Direct) |
View |
2023-01-20 Option Award |
2023-01-24 4:20 pm |
N/A 2033-01-20 |
Mirati Therapeutics Inc. | MRTX | Davis Aaron I. Director 10% Owner |
11,964 | $0 | 55,037 (Direct) |
View |
2023-01-20 Option Award |
2023-01-24 4:20 pm |
N/A 2033-01-20 |
Mirati Therapeutics Inc. | MRTX | BAUM CHARLES M President,Founder,Head of R&D |
11,964 | $0 | 180,741 (Direct) |
View |
2023-01-20 Option Award |
2023-01-24 4:19 pm |
N/A 2033-01-20 |
Mirati Therapeutics Inc. | MRTX | Johnson Craig A Director |
11,964 | $0 | 17,985 (Direct) |
View |
2023-01-20 Option Award |
2023-01-24 4:18 pm |
N/A 2033-01-20 |
Mirati Therapeutics Inc. | MRTX | Cherrington Julie M Director |
11,964 | $0 | 11,964 (Direct) |
View |
2023-01-20 Option Award |
2023-01-24 4:17 pm |
N/A 2033-01-20 |
Mirati Therapeutics Inc. | MRTX | Hasnain Faheem Director |
17,049 | $0 | 25,766 (Direct) |
View |
2023-01-20 Option Award |
2023-01-24 4:03 pm |
N/A 2033-01-20 |
Mirati Therapeutics Inc. | MRTX | Sharp Shalini Director |
11,964 | $0 | 16,934 (Direct) |
View |
2023-01-20 Option Award |
2023-01-24 4:00 pm |
N/A 2033-01-20 |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP, Chief Scientific Officer |
72,320 | $0 | 170,198 (Direct) |
View |
2023-01-20 Option Award |
2023-01-24 4:00 pm |
N/A 2033-01-20 |
Mirati Therapeutics Inc. | MRTX | Meek David D. Chief Executive Officer |
240,612 | $0 | 302,404 (Direct) |
View |
2023-01-20 Option Award |
2023-01-24 4:00 pm |
N/A 2033-01-20 |
Mirati Therapeutics Inc. | MRTX | Hickey Benjamin EVP, Chief Commercial Officer |
81,850 | $0 | 129,073 (Direct) |
View |
2023-01-20 Option Award |
2023-01-24 4:00 pm |
N/A 2033-01-20 |
Mirati Therapeutics Inc. | MRTX | CARTER BRUCE L A Director |
11,964 | $0 | 17,985 (Direct) |
View |
2023-01-20 Option Award |
2023-01-24 4:00 pm |
N/A 2033-01-20 |
Mirati Therapeutics Inc. | MRTX | Stelzer Laurie CFO |
72,320 | $0 | 130,118 (Direct) |
View |
2023-01-20 Option Award |
2023-01-24 4:00 pm |
N/A 2033-01-20 |
Mirati Therapeutics Inc. | MRTX | FUCHS HENRY J Director |
11,964 | $0 | 17,985 (Direct) |
View |
2023-01-20 Option Award |
2023-01-24 4:00 pm |
N/A 2033-01-20 |
Mirati Therapeutics Inc. | MRTX | Martinez Maria E Director |
11,964 | $0 | 17,985 (Direct) |
View |
2022-12-19 Option Award |
2022-12-21 9:21 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | BAUM CHARLES M President,Founder,Head of R&D |
53,618 | $0 | 172,425 (Direct) |
View |
2022-12-19 Option Award |
2022-12-21 9:20 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Hickey Benjamin EVP, Chief Commercial Officer |
19,149 | $0 | 50,877 (Direct) |
View |
2022-12-19 Option Award |
2022-12-21 9:20 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Meek David D. Chief Executive Officer |
35,425 | $0 | 64,971 (Direct) |
View |
2022-11-28 Exercise |
2022-11-28 7:01 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | BAUM CHARLES M President,Founder,Head of R&D |
69,256 | $17.41 | 197,157 (Direct) |
View |
2022-11-28 Exercise |
2022-11-28 7:01 pm |
N/A 2024-05-20 |
Mirati Therapeutics Inc. | MRTX | BAUM CHARLES M President,Founder,Head of R&D |
69,256 | $0 | 197,157 (Direct) |
View |
2022-11-07 Option Award |
2022-11-08 6:00 pm |
N/A 2032-11-06 |
Mirati Therapeutics Inc. | MRTX | Sandler Alan B. Chief Medical Officer |
105,000 | $0 | 105,000 (Direct) |
View |